Peptide status guide
What "research use only" means in peptide product labeling
Use the document map to compare seller wording with approval, intended-use, supplier-COA, and human-evidence records.
TL;DR
Open each record separately: the product label, seller context, approval record, evidence record, safety record, and batch record.
Key takeaways
- A March 31, 2026 FDA Gram Peptides warning letter about retatrutide, tirzepatide, and bacteriostatic water said the agency found evidence of intended human drug use even though the product labeling used research-use-only and not-for-human-consumption language.[1]
- FDA's May 4, 2026 approval guide says new human drugs and biological products generally need FDA approval before interstate marketing, sale, or shipment.[2]
- FDA says compounded drugs are not FDA-approved and receive no agency premarket review for safety, effectiveness, or quality.[3]
- FDA's supplement manufacturing guide says a relied-on supplier COA includes the test methods, limits, and actual results. The research-use phrase supplies none of those fields by itself.[4]
- FDA's April 22, 2026 BPC-157 entry says route-specific safety data are absent or limited. It also flags immunogenicity, peptide impurities, and active-ingredient characterization.[5]
The research phrase carries one narrow message
| Question | What the phrase contributes | Document that carries the answer |
|---|---|---|
| QuestionWhat use does the seller print? | What the phrase contributesA stated research-only position. | Document that carries the answerThe label plus the seller's surrounding claims and conduct.[1] |
| QuestionIs the product FDA-approved for human use? | What the phrase contributesNo approval evidence. | Document that carries the answerThe current FDA approval record.[2] |
| QuestionDoes the batch match a stated identity or result? | What the phrase contributesThe phrase contains none of the supplier-COA fields named in FDA's supplement manufacturing guide.[4] | Document that carries the answerFor the guide's dietary supplement context, the supplier COA carries methods, limits, and actual results. Material traceability sits in separate manufacturing records.[4] |
| QuestionIs human safety established? | What the phrase contributesThe phrase is not a human-safety record. | Document that carries the answerSubstance-specific human evidence and current regulator records. FDA says safety information for proposed BPC-157 routes is absent or limited.[5] |
FDA reads the seller's full context
FDA's March 31, 2026 Gram Peptides letter is one concrete example. It covered retatrutide, tirzepatide, and bacteriostatic water offered for sale. The letter acknowledged research-use-only and not-for-human-consumption statements, then described website evidence that FDA said established intended human drug use.[1]
In that warning letter, FDA treated the seller's website claims as product labeling and used them as intended-use evidence alongside the research-use-only wording. The letter is an example of that reading, not a universal verdict on every seller.[1]
The next record depends on the question
- Approval question: use FDA's current product or approval record, not a seller's badge or disclaimer.[2]
- Compounding question: FDA states directly that compounded drugs are not FDA-approved and lack agency premarket review.[3]
- Testing question: FDA's cited guide covers a supplier component COA used in dietary supplement manufacturing. It names the analytical method, acceptance limit, and actual result.[4]
- Safety question: read the named substance's human data and current regulator record. FDA's BPC-157 page flags gaps and impurity-related complexity rather than filling them with a general class assumption.[5]
The Peptide COA vs Supplement Facts guide explains what a testing document can establish after the status question is separated out.
pepSmart can organize the substance context
The pepSmart peptide library provides a deeper reference layer for named substances. It does not replace the current FDA record, a batch-linked report, or published human evidence.
Start with the question being asked. Status comes from the official record. Testing claims come from the matched testing document. Human claims stay with human evidence on the same substance and route.
Related peptide label guides
Peptide label guide
Peptide supplements vs injections: label and record checks
A document-first map for comparing product labels, facility records, FDA records, and certificates. It separates the question each record can answer.
Peptide document guide
Peptide COA vs Supplement Facts: what each can prove
Use the field-by-field guide to compare a Supplement Facts panel with a supplier COA without treating either document as proof of the other.
Peptide evidence guide
Collagen peptides vs BPC-157: two evidence records
Use the side-by-side guide to keep collagen, BPC-157, formulation, route, population, and regulatory status in separate evidence lanes.
Label scam guide
Supplement label scams: FDA-approved claims and fake badges
Check approval wording, testing badges, proprietary blends, and dose claims without treating marketing as evidence.
Sources behind this guide
- Gram Peptides MARCS-CMS 721806 - March 31, 2026. U.S. Food and Drug Administration. Source date: 2026-03-31.
- Is It Really 'FDA Approved'?. U.S. Food and Drug Administration. Source date: 2026-05-04.
- Understanding the Risks of Compounded Drugs. U.S. Food and Drug Administration. Source date: 2026-06-22.
- Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. U.S. Food and Drug Administration. Content current as of: 2018-09-20.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. Source date: 2026-04-22.
Seller pages need a retrieval date
Web copy can change. A dated capture of the exact product page preserves what the seller stated when the intended-use record was checked.
NutriScore has not commissioned independent clinical review of this article.
Read the editorial process and contributor disclosure and the scoring methodology.
Corrections: support@nutriscore.fit.
Sources: 5 entries, all primary canon, last reviewed 2026-08-26.
For research and educational purposes only. Not medical advice.